Cargando…
The impact of preformed donor‐specific antibodies in living donor liver transplantation according to graft volume
INTRODUCTION: The roles of preformed anti‐HLA donor‐specific antibodies (DSAs) in liver transplantation remain controversial. We evaluated the impact of preformed DSAs in living donor liver transplantation. METHODS: Adults who underwent living donor liver transplantation (n = 175) in our institute w...
Autores principales: | Goto, Ryoichi, Ito, Makoto, Kawamura, Norio, Watanabe, Masaaki, Ganchiku, Yoshikazu, Kamiyama, Toshiya, Shimamura, Tsuyoshi, Taketomi, Akinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926496/ https://www.ncbi.nlm.nih.gov/pubmed/35064772 http://dx.doi.org/10.1002/iid3.586 |
Ejemplares similares
-
Long‐term risk of a fatty liver in liver donors
por: Goto, Ryoichi, et al.
Publicado: (2023) -
Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
por: Fujii, Yuki, et al.
Publicado: (2020) -
Living Donor Liver Transplantation for Hepatic Venoocclusive Disease/Sinusoidal Obstruction Syndrome Originating from Hematopoietic Stem Cell Transplantation
por: Ichimura, Kentaro, et al.
Publicado: (2022) -
Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
por: Goto, Ryoichi, et al.
Publicado: (2023) -
Petersen’s hernia after living donor liver transplantation
por: Sakamoto, Sodai, et al.
Publicado: (2017)